Alopecia With Endocrine Therapies in Patients With Cancer

September 2013 in “ Oncologist ”

Vishal Raj Saggar, Shenhong Wu, Maura N. Dickler, Mario E. Lacouture

alopecia endocrine therapies tamoxifen hair loss psychosocial impact supportive care treatments

TLDR Endocrine therapies for cancer significantly increase the risk of hair loss.

The document analyzed the incidence and risk of alopecia in 19,430 patients across 35 clinical trials, with 13,415 patients receiving endocrine therapies for cancer and 6,015 serving as controls. The overall incidence of all-grade alopecia was 4.4%, with the highest incidence observed in patients treated with tamoxifen at 25.4%. The relative risk of alopecia with endocrine therapy compared to placebo was 12.88, indicating a significantly increased risk. The study concluded that alopecia is a common but underreported side effect of endocrine-based cancer therapies, with a significant impact on patients' quality of life. It highlighted the importance of pretherapy counseling, identifying risk factors, and developing interventions to manage the psychosocial impact of alopecia. The document also discussed the biological mechanisms of hair loss associated with endocrine therapies and suggested supportive care treatments.

View this study on theoncologist.alphamedpress.org →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

Hair Shaft Abnormalities After Chemotherapy and Tamoxifen Therapy in Patients With Breast Cancer Evaluated by Optical Coherence Tomography

research Hair Shaft Abnormalities After Chemotherapy and Tamoxifen Therapy in Patients With Breast Cancer Evaluated by Optical Coherence Tomography

16 citations, October 2012 in “British Journal of Dermatology”

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

research Evidence-Based Treatments for Female Pattern Hair Loss: A Summary of a Cochrane Systematic Review

40 citations, October 2012 in “British Journal of Dermatology”

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

research Hair Loss in Women: Medical and Cosmetic Approaches to Increase Scalp Hair Fullness

75 citations, December 2011 in “British Journal of Dermatology”

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

research Hair Loss in Women

129 citations, October 2007 in “The New England Journal of Medicine”

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

research Protection Against Chemotherapy-Induced Alopecia

97 citations, September 2006 in “Pharmaceutical Research”

No treatment fully prevents hair loss from chemotherapy yet.

research Treatment of Hair Loss

370 citations, September 1999 in “The New England Journal of Medicine”

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

research The Biology of Hair Follicles

1113 citations, August 1999 in “The New England Journal of Medicine”

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Similar Research

5 / 1000+ results

research Hair Disorders in Patients with Cancer

53 citations, April 2018 in “Journal of The American Academy of Dermatology”

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

research Supportive Oncodermatology: Addressing Dermatologic Adverse Events Associated with Oncologic Therapies

3 citations, November 2018 in “Oncology issues”

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

research Management of Alopecia Due to Cancer Therapies

1 citations, January 2018 in “Springer eBooks”

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

research Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia

43 citations, March 2019 in “JAMA Dermatology”

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Analysis of Quantitative Changes in Hair Growth During Treatment With Chemotherapy or Tamoxifen in Patients With Breast Cancer: A Cohort Study

research Analysis of Quantitative Changes in Hair Growth During Treatment With Chemotherapy or Tamoxifen in Patients With Breast Cancer: A Cohort Study

24 citations, November 2013 in “British Journal of Dermatology”

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Alopecia With Endocrine Therapies in Patients With Cancer

Research cited in this study

research Hair Shaft Abnormalities After Chemotherapy and Tamoxifen Therapy in Patients With Breast Cancer Evaluated by Optical Coherence Tomography

research Evidence-Based Treatments for Female Pattern Hair Loss: A Summary of a Cochrane Systematic Review

research Hair Loss in Women: Medical and Cosmetic Approaches to Increase Scalp Hair Fullness

research Hair Loss in Women

research Protection Against Chemotherapy-Induced Alopecia

research Treatment of Hair Loss

research The Biology of Hair Follicles

Related Community Posts Join

community 5 Month Dutasteride Progress Before and After

community What 3 months without fin& min does😔

community I started rapidly diffuse thinning at 22. I'm 42 now and have as much hair as I did at 16. AMA

community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men

community Reminder how little the average person knows about hair loss

community I've been afraid to start Finasteride treatment for 5 years, on it for 2 weeks, regret that hadn't started it earlier and here's my story